Sigma Planning Corp’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,269
Closed -$859K 1363
2025
Q4
$859K Buy
1,269
+102
+9% +$69.5K 0.02% 592
2025
Q3
$746K Buy
1,167
+626
+116% +$380K 0.02% 642
2025
Q2
$290K Buy
541
+36
+7% +$17.2K 0.01% 1004
2025
Q1
$212K Sell
505
-210
-29% -$91.2K 0.01% 1102
2024
Q4
$296K Sell
715
-1,177
-62% -$516K 0.01% 932
2024
Q3
$956K Buy
1,892
+212
+13% +$103K 0.03% 518
2024
Q2
$818K Buy
1,680
+106
+7% +$53.2K 0.03% 538
2024
Q1
$850K Buy
1,574
+444
+39% +$243K 0.03% 550
2023
Q4
$627K Sell
1,130
-306
-21% -$144K 0.05% 387
2023
Q3
$628K Buy
1,436
+147
+11% +$73.3K 0.02% 612
2023
Q2
$647K Sell
1,289
-85
-6% -$40.7K 0.02% 632
2023
Q1
$687K Buy
1,374
+286
+26% +$137K 0.02% 671
2022
Q4
$444K Buy
1,088
+32
+3% +$12.4K 0.02% 807
2022
Q3
$344K Buy
1,056
+11
+1% +$4.04K 0.01% 893
2022
Q2
$367K Sell
1,045
-279
-21% -$114K 0.01% 892
2022
Q1
$724K Sell
1,324
-176
-12% -$92.6K 0.02% 675
2021
Q4
$988K Sell
1,500
-17
-1% -$10.7K 0.03% 551
2021
Q3
$943K Buy
1,517
+33
+2% +$22.2K 0.03% 559
2021
Q2
$937K Buy
1,484
+477
+47% +$263K 0.03% 578
2021
Q1
$493K Sell
1,007
-3
-0.3% -$1.5K 0.02% 774
2020
Q4
$505K Sell
1,010
-357
-26% -$160K 0.02% 688
2020
Q3
$537K Sell
1,367
-390
-22% -$144K 0.02% 583
2020
Q2
$580K Buy
+1,757
New +$509K 0.03% 542
2020
Q1
Sell
-1,158
Closed -$302K 1008
2019
Q4
$302K Sell
1,158
-184
-14% -$48.5K 0.01% 796
2019
Q3
$365K Buy
1,342
+433
+48% +$120K 0.02% 691
2019
Q2
$250K Buy
+909
New +$224K 0.01% 816

Other funds holding IDXX

Sigma Planning Corp's IDXX Position: Q1 2026 in Review

Sigma Planning Corp sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 1,269 shares — an estimated $859K sold.

Sigma Planning Corp first reported a position in IDXX in Q2 2019 and held it in 26 quarters. The position peaked at $988K in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Sigma Planning Corp reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Sigma Planning Corp sold 1,269 Idexx Laboratories shares in Q1 2026, an estimated $859K.
  • Sigma Planning Corp first reported a position in Idexx Laboratories in Q2 2019 and held it in 26 quarters.
  • Sigma Planning Corp's Idexx Laboratories position peaked at $988K in Q4 2021.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Sigma Planning Corp's 13F filing for Q1 2026, filed 4 May 2026.